Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.

Abstract excerpt

Traditional cross-sectional tumor imaging focuses solely on tumor morphology. With the introduction of targeted biological therapies in human trials, morphologic change may lag behind other physiologic measures of response on clinical images. Dynamic contrast-enhanced magnetic resonance imaging (...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Vessels
• Share to Carcinoma, Renal Cell
• Share to Contrast Media